This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balzarini, J.
Right arrow Articles by Karlsson, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balzarini, J.
Right arrow Articles by Karlsson, A.

 Previous Article  |  Next Article 

Journal of Virology, July 2001, p. 5772-5777, Vol. 75, No. 13
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.13.5772-5777.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Exploitation of the Low Fidelity of Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase and the Nucleotide Composition Bias in the HIV-1 Genome To Alter the Drug Resistance Development of HIV

Jan Balzarini,1,* Maria-José Camarasa,2 Maria-Jesus Pérez-Pérez,2 Ana San-Félix,2 Sonsoles Velázquez,2 Carlo-Federico Perno,3 Erik De Clercq,1 John N. Anderson,4 and Anna Karlsson5

Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium1; Instituto de Química Médica, Consejo Superior Investigaciones Cientificas (CSIC), 28006 Madrid, Spain2; Department of Experimental Medicine, University of Rome "Tor Vergata," I-00135 Rome, Italy3; Department of Biological Sciences, Purdue University, West Lafayette, Indiana 479074; and Karolinska Institute, Division of Clinical Virology F68, Huddinge University Hospital, S-141 86 Huddinge/Stockholm, Sweden5

Received 27 December 2000/Accepted 30 March 2001

The RNA genome of the lentivirus human immunodeficiency virus type 1 (HIV-1) is significantly richer in adenine nucleotides than the statistically equal distribution of the four different nucleotides that is expected. This compositional bias may be due to the guanine-to-adenine (Gright-arrowA) nucleotide hypermutation of the HIV genome, which has been explained by dCTP pool imbalances during reverse transcription. The adenine nucleotide bias together with the poor fidelity of HIV-1 reverse transcriptase markedly enhances the genetic variation of HIV and may be responsible for the rapid emergence of drug-resistant HIV-1 strains. We have now attempted to counteract the normal mutational pattern of HIV-1 in response to anti-HIV-1 drugs by altering the endogenous deoxynucleoside triphosphate pool ratios with antimetabolites in virus-infected cell cultures. We showed that administration of these antimetabolic compounds resulted in an altered drug resistance pattern due to the reversal of the predominant mutational flow of HIV (Gright-arrowA) to an adenine-to-guanine (Aright-arrowG) nucleotide pattern in the intact HIV-1-infected lymphocyte cultures. Forcing the virus to change its inherent nucleotide bias may lead to better control of viral drug resistance development.


* Corresponding author. Mailing address: Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium. Phone: (32) 16 337341. Fax: (32) 16 337340. E-mail: jan.balzarini{at}rega.kuleuven.ac.be.


Journal of Virology, July 2001, p. 5772-5777, Vol. 75, No. 13
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.13.5772-5777.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • O'Neil, P. K., Sun, G., Yu, H., Ron, Y., Dougherty, J. P., Preston, B. D. (2002). Mutational Analysis of HIV-1 Long Terminal Repeats to Explore the Relative Contribution of Reverse Transcriptase and RNA Polymerase II to Viral Mutagenesis. J. Biol. Chem. 277: 38053-38061 [Abstract] [Full Text]